225 related articles for article (PubMed ID: 24562809)
1. Development of vorinostat-loaded solid lipid nanoparticles to enhance pharmacokinetics and efficacy against multidrug-resistant cancer cells.
Tran TH; Ramasamy T; Truong DH; Shin BS; Choi HG; Yong CS; Kim JO
Pharm Res; 2014 Aug; 31(8):1978-88. PubMed ID: 24562809
[TBL] [Abstract][Full Text] [Related]
2. Hyaluronic acid-coated solid lipid nanoparticles for targeted delivery of vorinostat to CD44 overexpressing cancer cells.
Tran TH; Choi JY; Ramasamy T; Truong DH; Nguyen CN; Choi HG; Yong CS; Kim JO
Carbohydr Polym; 2014 Dec; 114():407-415. PubMed ID: 25263908
[TBL] [Abstract][Full Text] [Related]
3. Exploration of docetaxel palmitate and its solid lipid nanoparticles as a novel option for alleviating the rising concern of multi-drug resistance.
Kaushik L; Srivastava S; Panjeta A; Chaudhari D; Ghadi R; Kuche K; Malik R; Preet S; Jain S; Raza K
Int J Pharm; 2020 Mar; 578():119088. PubMed ID: 32001291
[TBL] [Abstract][Full Text] [Related]
4. Beta-carotene-Encapsulated Solid Lipid Nanoparticles (BC-SLNs) as Promising Vehicle for Cancer: an Investigative Assessment.
Jain A; Sharma G; Thakur K; Raza K; Shivhare US; Ghoshal G; Katare OP
AAPS PharmSciTech; 2019 Feb; 20(3):100. PubMed ID: 30721373
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of Anti-Tumor Efficacy of Vorinostat Encapsulated Self-Assembled Polymeric Micelles in Solid Tumors.
Rompicharla SVK; Trivedi P; Kumari P; Muddineti OS; Theegalapalli S; Ghosh B; Biswas S
AAPS PharmSciTech; 2018 Oct; 19(7):3141-3151. PubMed ID: 30132129
[TBL] [Abstract][Full Text] [Related]
6. Development of Domperidone Solid Lipid Nanoparticles: In Vitro and In Vivo Characterization.
Shazly GA; Alshehri S; Ibrahim MA; Tawfeek HM; Razik JA; Hassan YA; Shakeel F
AAPS PharmSciTech; 2018 May; 19(4):1712-1719. PubMed ID: 29532427
[TBL] [Abstract][Full Text] [Related]
7. Co-delivery of Vorinostat and Etoposide Via Disulfide Cross-Linked Biodegradable Polymeric Nanogels: Synthesis, Characterization, Biodegradation, and Anticancer Activity.
Kumar P; Wasim L; Chopra M; Chhikara A
AAPS PharmSciTech; 2018 Feb; 19(2):634-647. PubMed ID: 28948528
[TBL] [Abstract][Full Text] [Related]
8. Ceramide and N,N,N-Trimethylphytosphingosine-Iodide (TMP-I)-Based Lipid Nanoparticles for Cancer Therapy.
Balakrishnan P; Song CK; Jahn A; Cho HJ
Pharm Res; 2016 Jan; 33(1):206-16. PubMed ID: 26337769
[TBL] [Abstract][Full Text] [Related]
9. Self-reporter shikonin-Act-loaded solid lipid nanoparticle: formulation, physicochemical characterization and geno/cytotoxicity evaluation.
Eskandani M; Nazemiyeh H
Eur J Pharm Sci; 2014 Aug; 59():49-57. PubMed ID: 24768857
[TBL] [Abstract][Full Text] [Related]
10. Naringenin-loaded solid lipid nanoparticles: preparation, controlled delivery, cellular uptake, and pulmonary pharmacokinetics.
Ji P; Yu T; Liu Y; Jiang J; Xu J; Zhao Y; Hao Y; Qiu Y; Zhao W; Wu C
Drug Des Devel Ther; 2016; 10():911-25. PubMed ID: 27041995
[TBL] [Abstract][Full Text] [Related]
11. Fabrication of solid lipid nanoparticles of lurasidone HCl for oral delivery: optimization,
Patel MH; Mundada VP; Sawant KK
Drug Dev Ind Pharm; 2019 Aug; 45(8):1242-1257. PubMed ID: 30880488
[No Abstract] [Full Text] [Related]
12. Capecitabine lipid nanoparticles for anti-colon cancer activity in 1,2-dimethylhydrazine-induced colon cancer: preparation, cytotoxic, pharmacokinetic, and pathological evaluation.
Dudhipala N; Puchchakayala G
Drug Dev Ind Pharm; 2018 Oct; 44(10):1572-1582. PubMed ID: 29493289
[TBL] [Abstract][Full Text] [Related]
13. Raloxifene-loaded SLNs with enhanced biopharmaceutical potential: QbD-steered development, in vitro evaluation, in vivo pharmacokinetics, and IVIVC.
Jain A; Sharma T; Kumar R; Katare OP; Singh B
Drug Deliv Transl Res; 2022 May; 12(5):1136-1160. PubMed ID: 33966178
[TBL] [Abstract][Full Text] [Related]
14. Development of lipid-based nanoparticles for enhancing the oral bioavailability of paclitaxel.
Pandita D; Ahuja A; Lather V; Benjamin B; Dutta T; Velpandian T; Khar RK
AAPS PharmSciTech; 2011 Jun; 12(2):712-22. PubMed ID: 21637945
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetic and pharmacodynamic studies of nisoldipine-loaded solid lipid nanoparticles developed by central composite design.
Dudhipala N; Veerabrahma K
Drug Dev Ind Pharm; 2015; 41(12):1968-77. PubMed ID: 25830370
[TBL] [Abstract][Full Text] [Related]
16. Evading P-glycoprotein mediated-efflux chemoresistance using Solid Lipid Nanoparticles.
Cavaco MC; Pereira C; Kreutzer B; Gouveia LF; Silva-Lima B; Brito AM; Videira M
Eur J Pharm Biopharm; 2017 Jan; 110():76-84. PubMed ID: 27810470
[TBL] [Abstract][Full Text] [Related]
17. Curcumin-loaded solid lipid nanoparticles have prolonged in vitro antitumour activity, cellular uptake and improved in vivo bioavailability.
Sun J; Bi C; Chan HM; Sun S; Zhang Q; Zheng Y
Colloids Surf B Biointerfaces; 2013 Nov; 111():367-75. PubMed ID: 23856543
[TBL] [Abstract][Full Text] [Related]
18. Ethyl oleate-containing nanostructured lipid carriers improve oral bioavailability of trans-ferulic acid ascompared with conventional solid lipid nanoparticles.
Zhang Y; Li Z; Zhang K; Yang G; Wang Z; Zhao J; Hu R; Feng N
Int J Pharm; 2016 Sep; 511(1):57-64. PubMed ID: 27374194
[TBL] [Abstract][Full Text] [Related]
19. Vitamin E TPGS Emulsified Vinorelbine Bitartrate Loaded Solid Lipid Nanoparticles (SLN): Formulation Development, Optimization and In vitro Characterization.
Maurya L; Singh S; Rajamanickam VM; Narayan G
Curr Drug Deliv; 2018; 15(8):1135-1145. PubMed ID: 29629662
[TBL] [Abstract][Full Text] [Related]
20. pH-Responsive therapeutic solid lipid nanoparticles for reducing P-glycoprotein-mediated drug efflux of multidrug resistant cancer cells.
Chen HH; Huang WC; Chiang WH; Liu TI; Shen MY; Hsu YH; Lin SC; Chiu HC
Int J Nanomedicine; 2015; 10():5035-48. PubMed ID: 26346762
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
